Tezacaftor

CAS : 1152311-62-0

Ref. TR-T321510

Informations sur le produit

• Nom: Tezacaftor
• Synonymes: VX 661,1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]cyclopropanecarboxamide (ACI), 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]cyclopropanecarboxamide, (R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, (R)-1-(2,2-Difluorobenzo[D] [1,3]Dioxol-5-Yl)-N-(1-(2,3-Dihydroxypropyl)-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-Yl)-1H-Indol-5-Yl) Cyclopropanecarboxamide, 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methyl-2-propanyl)-1H-indol-5-yl}cyclopropanecarboxamide, Cs-1078, Cyclopropanecarboxamide, 1-(2,2-Difluoro-1,3-Benzodioxol-5-Yl)-N-[1-[(2R)-2,3-Dihydroxypropyl]-6-Fluoro-2-(2-Hydroxy-1,1-Dimethylethyl)-1H-Indol-5-Yl]-, VX 661

Description

Applications Tezacaftor is used as a combination therapy with Ivacaftor for the treatment of patients with cystic fibrosis.
References Rowe, S. M., et al.: N. Engl. J. Med., 377, 2024 (2017); Dhooghe, B., et al.: Exp. Opin. Investig. Drugs, 25, 423 (2016)

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 520.5
• Formule: C₂₆H₂₇F₃N₂O₆
• Couleur/Forme: White To Light Yellow
• InChI: InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1
• Code InChI: InChIKey=MJUVRTYWUMPBTR-MRXNPFEDSA-N
• SMILES: CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO